Revenue skyrockets fivefold, surpassing OpenAI: Anthropic annualizes $45 billion and is the first to achieve profitability
According to monitoring by Beating, the latest financial data shows that Anthropic’s annualized operating revenue has soared to nearly $45 billion, not only achieving a 5-fold surge in the first five months of 2026, but also surpassing OpenAI by about 35%. In contrast, OpenAI’s current annualized revenue growth has markedly slowed, remaining only in the $30–33 billion range. At the end of last year, Anthropic’s annualized revenue was just $9 billion, less than half of OpenAI’s. This overtaking has not only shocked the industry but also introduced significant uncertainty to the upcoming IPO battle between the two companies.
Even more dramatic is the difference in the two companies’ profitability. Thanks to strong demand from enterprise clients for high-value services, Anthropic is expected to achieve $559 million in operating profit in the second quarter, with an operating profit margin of 5%, turning profitable ahead of its rival. In contrast, OpenAI has fallen deeply into a severe loss scenario. Burdened by tens of billions in server rental costs and supporting hundreds of millions of free users, OpenAI’s operating profit margin in the first quarter was -122%, equivalent to a net loss of at least $7 billion in a single quarter, with an annual burn budget of up to $25 billion.
Differing business structures also highlight each company’s advantages. Anthropic focuses on selling code-writing and white-collar automation tools to enterprises, and even allows distributor income from cloud service providers to be consolidated into its accounts. By comparison, OpenAI must permanently surrender 20% of its revenue to Microsoft and is forced to scale down high-energy-consuming projects such as the Sora video model to cut costs. OpenAI CFO Sarah Friar once expressed concerns to CEO Sam Altman about the rush to go public, but with Anthropic—financially stronger and already profitable—pressing hard, heading to the stock market for funding may have become OpenAI’s only option.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Shares of Oxford Metrics in the UK fell as the company forecast a fiscal year loss, while the market had previously generally expected the company to turn a profit.
On October 9th, shares of smart sensing technology company Oxford Metrics OMG1.L fell by 14% to 30 pence, marking their lowest level since March 2015. The company expects an adjusted operating loss of between £500,000 and £3.9 million for fiscal 2026, while the market consensus was for a profit of £3 million. Oxford Metrics noted that key markets served by its motion capture division, Vicon, remain soft, with R&D funding under pressure and major projects in the industrial vision and measurement systems business facing delays. The company has acquired the assets of Move AI to enhance Vicon’s AI-based motion capture technology and reach more customers and markets. Year-to-date, the share price has dropped about 45%, including the decline on the day. (For the convenience of non-English speakers, Reuters has automated translation of its reports into various other languages. As automated translation may be inaccurate or lack necessary context, Reuters does not guarantee the accuracy of the translated text and provides it as a convenience only. Reuters is not responsible for any damage or loss caused by the use of automated translation features.)
BUZZ-European telecom stocks fall after SpaceX reaches spectrum agreement
On Thursday, SpaceX SPCX.O announced it had reached an agreement (link) to acquire a portfolio of low-frequency band spectrum licenses across the United States, which will enable Starlink Mobile to become a major telecommunications operator in the US. Following this news, shares of European telecom service providers fell by 3% to 7%. Deutsche Telekom DTEGn.DE, which holds a 54% stake in T-Mobile US TMUS.O, saw its share price drop by 7%, set for its biggest single-day loss since June 2023. “Deutsche Telekom is negatively impacted as competition in the US market intensifies,” according to a local trader. This acquisition could potentially allow SpaceX to provide direct mobile communication services to smartphones from space in the future. Scotiabank pointed out, “SpaceX’s acquisition of spectrum in the US today makes the threat of hybrid networks more realistic, though network capacity and deployment economics in dense markets have yet to be validated.” Spanish operator Telefonica TEF.MC, France's Orange SA ORAN.PA, and UK’s Vodafone VOD.L all declined by about 3%. The European STOXX 600 telecom index .SXKP dropped 2.8%. (For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Since these automated translations may contain errors or lack the needed context, Reuters does not guarantee the accuracy of automated translation texts and provides them for reader convenience only. Reuters bears no responsibility for any harm or loss due to use of automated translation.)
10-Yr Benchmark Govt Yields - U.S. vs Other Nations
Current Spread in Yield Basis Points U.S. 5.243 % Australia 5.345 % 10.2 Belgium 4.295 % -94.8 Canada 3.929 % -131.4 Denmark 3.260 % -198.4 France 4.816 % -42.7 Germany 3.474 % -177.0 Italy 4.540 % -70.3 Japan 3.017 % -222.6 Netherlands 3.577 % -166.6 Spain 4.064 % -117.9 Sweden 3.205 % -203.8 U.K. 5.427 % 18.4 Source: Tullett Prebon via FactSet (END) Dow Jones Newswires October 09, 2026 04:10 ET (08:10 GMT)
TRexBio Prices $116.7 Million Initial Public Offering
04:10 AM EDT, 10/09/2026 (MT Newswires) -- TRexBio (TRXB) said Thursday it priced its initial public offering of roughly 8.3 million common shares at $14 per share. The company expects to raise roughly $116.7 million in gross proceeds from the sale, and its stock is expected to begin trading Friday on the Nasdaq Global Select Market (NDAQ) under the ticker symbol TRXB, the company said. Underwriters have a 30-day option to buy up to an additional 1.25 million shares, and the transaction is expected to close Oct. 13, pending customary conditions, TRexBio said.
